Fanpu Ji

Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study

Zhi‐Cheng Jin, Jian-Jia Chen, Xiaoli Zhu et al. · EClinicalMedicine · 2024 · 143 citations · Full text

Medicine, Oncology, Pharmacology +17

Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation

Shu Su, William C.W. Wong, Zhuoru Zou et al. · The Lancet Global Health · 2022 · 120 citations · Full text

Pharmacy, Pharmacoeconomics, Preventive Medicine +14

Impact of the COVID-19 pandemic on liver disease-related mortality rates in the United States

Xu Gao, Fan Lv, Xinyuan He et al. · Journal of Hepatology · 2022 · 98 citations · Full text

Medicine, Infectious Diseases, Preventive Medicine +16

Association of Direct-Acting Antiviral Therapy With Liver and Nonliver Complications and Long-term Mortality in Patients With Chronic Hepatitis C

Eiichi Ogawa, Nicholas Chien, Leslie Y. Kam et al. · JAMA Internal Medicine · 2022 · 89 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Immune Checkpoint Inhibitors for Child-Pugh Class B Advanced Hepatocellular Carcinoma

Enrui Xie, Yee Hui Yeo, Bernhard Scheiner et al. · JAMA Oncology · 2023 · 82 citations · Full text

Life Sciences, Immunology, Oncology +14